India On Covid Vaccines
- All
- News
- Videos
- Web Stories
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Man Who Took 217 Covid Vaccines Has Fully Functional Immune System: Study
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.
-
India Ended Covid As "A Country Of Contribution": S Jaishankar
Elaborating on the challenges faced by the country during COVID-19, S Jaishankar said that India entered the pandemic as a country of "worry" and ended it as a country of "contribution" by providing vaccines to hundreds of countries.
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
Covid Vaccination Didn't Increase Risk Of Sudden Death Among Adults: Minister
A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the government informed Parliament on Friday.
-
Found No Proof Of Covid Vaccine Causing Sudden Death, Says Top Medical Body
Indian researchers found no evidence that COVID-19 vaccination was behind "unexplained sudden deaths", a medical organisation said on Tuesday, instead pointing to the disease itself, binge drinking and intense exercise as risk factors.
-
UK Rolls Out Winter Top-Up Vaccines Amid New Covid Variant Fears
The UK health authorities began rolling out their winter vaccine schedule for the most medically vulnerable on Monday, brought forward from a planned early October rollout amid concerns around the new COVID variant BA.2.86.
-
No Link Between Covid Vaccines Used In India And Heart Attack Risk: Study
The research, published recently in the journal PLOS One, determined the impact of COVID-19 vaccination on mortality following acute myocardial infarction (AMI) or heart attack.
-
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
The study on factors related to the post-discharge mortality among hospitalized COVID patients study by ICMR revealed that vaccination before an infection provided 60% protection against post-discharge deaths.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
Man Who Took 217 Covid Vaccines Has Fully Functional Immune System: Study
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.
-
India Ended Covid As "A Country Of Contribution": S Jaishankar
Elaborating on the challenges faced by the country during COVID-19, S Jaishankar said that India entered the pandemic as a country of "worry" and ended it as a country of "contribution" by providing vaccines to hundreds of countries.
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
Covid Vaccination Didn't Increase Risk Of Sudden Death Among Adults: Minister
A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the government informed Parliament on Friday.
-
Found No Proof Of Covid Vaccine Causing Sudden Death, Says Top Medical Body
Indian researchers found no evidence that COVID-19 vaccination was behind "unexplained sudden deaths", a medical organisation said on Tuesday, instead pointing to the disease itself, binge drinking and intense exercise as risk factors.
-
UK Rolls Out Winter Top-Up Vaccines Amid New Covid Variant Fears
The UK health authorities began rolling out their winter vaccine schedule for the most medically vulnerable on Monday, brought forward from a planned early October rollout amid concerns around the new COVID variant BA.2.86.
-
No Link Between Covid Vaccines Used In India And Heart Attack Risk: Study
The research, published recently in the journal PLOS One, determined the impact of COVID-19 vaccination on mortality following acute myocardial infarction (AMI) or heart attack.
-
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
The study on factors related to the post-discharge mortality among hospitalized COVID patients study by ICMR revealed that vaccination before an infection provided 60% protection against post-discharge deaths.
